17β-Hydroxy-androstano[3,2-c]isoxazole is an analog of furazadrol and danazol, which are isoxazoles of testosterone that possess weak androgenic activity. 17β-Hydroxy-androstano[3,2-c]isoxazole is a designer anabolic androgenic steroid that is classified as a Schedule III controlled substance in the United States. This compound is intended for forensic and research purposes only.